Skip to main content
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.

  • Positive Results from Parkinson's LRRK2 Drug Trial

    New Therapy for Parkinson’s “Off” Time Reaches FDA

    A continuous apomorphine infusion, which aims to treat significant “off” time not controlled with oral PD meds, is now with the FDA for review.

  • ASAP logo and Scherzer team

    What We Fund: $161 Million to ASAP Initiative Teams

    The Aligning Science Across Parkinson’s (ASAP) initiative is funding 21 multidisciplinary teams investigating the biology of Parkinson’s genes or neuro-immune interactions.

  • Person smiling at camera.

    Fox DEN in Practice: Researcher Lands Top Abstract Recognition at Parkinson’s Congress

    We spoke with Meredith Bock, MD, to learn how she used the Fox DEN platform and landed top abstract designation at the International Parkinson and Movement Disorder Society Congress.

  • MDS Virtual Congress 2020 photo

    MJFF’s Guide to the International Congress of Parkinson's Disease and Movement Disorders

    Each year, the Congress brings together thousands of clinicians, researchers and members of industry working on movement disorders such as Parkinson’s.

  • Blood tests

    Research Perspective: Blood-Based Biomarkers in Parkinson’s

    Dr. Samanatha Hutten explains the progress so far in developing a blood-based biomarker for Parkinson's.

  • Biological assay in a 96-well plate

    Findings from Systemic Synuclein Sampling Study (S4) Published

    Results from the MJFF-sponsored S4 study were published in Neurology in a paper from lead investigator Lana M. Chahine, MD.

Gloved hand holding research samples.

Be Part of the Answer

You have the power to impact your future and the future of millions living with Parkinson's disease. Explore clinical research participation today.

Join a Study
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.